Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if UTHR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
139 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 1 days ago
Red flags: 6
886 filers reported a long position in UTHR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $2.9B | 5.3M | -1.9% |
| Avoro Capital Advisors LLC | $1.5B | 2.8M | +5.6% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1B | 1.9M | -4.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $1B | 1.9M | -2% |
| STATE STREET CORP | $1B | 1.9M | +2.9% |
| RENAISSANCE TECHNOLOGIES LLC | $925.8M | 1.7M | -4.4% |
| WELLINGTON MANAGEMENT GROUP LLP | $747.2M | 1.4M | -39.1% |
| GEODE CAPITAL MANAGEMENT, LLC | $538.9M | 996.6K | -19.2% |
| Jupiter Topco LLC | $450.1M | 831.1K | — |
| NORGES BANK | $376.4M | 694.8K | — |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.